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Objective. To determine changes in hemoglobin concentration at second measurements after a normal hemoglobin concentration
was detected at ﬁrst booking during pregnancy at low and at high altitudes. Methods. This is a secondary analysis of a large
database obtained from the Perinatal Information System in Peru which includes 379,816 pregnant women and their babies from
43 maternity units in Peru. Results. Most women remained with normal hemoglobin values at second measurement (75.1%).
However, 21.4% of women became anemic at the second measurement. In all, 2.8% resulted with moderate/severe anemia and
3.5% with erythrocytosis (Hb>14.5g/dL). In all cases Hb was higher as altitude increased. Risk for moderate/severe anemia
increased associated with higher gestational age at second measurement of hemoglobin, BMI <19.9kg/m2, living without partner,
<5 antenatal care visits, ﬁrst parity, multiparity, and preeclampsia. Lower risk for moderate/severe anemia was observed with
normal high Hb level at ﬁrst booking living at moderate and high altitude, and high BMI. Conclusion. Prevalence of anemia
increases as pregnancy progress, and that a normal value at ﬁrst booking may not be considered suﬃcient as Hb values should be
observed throughout pregnancy. BMI was a risk for anemia in a second measurement.
1.Introduction
Maternal moderate and severe anemia have been considered
as conditions that aﬀect adversely maternal and perinatal
outcomes. For such reason the identiﬁcation of these cases is
important since appropriate treatment may reduce the risk
for adverse outcomes. Iron is the most common treatment
currently used to control iron deﬁciency and anemia
particularly in low-income countries, where anemia is more
frequent [1].
Physiologically, hemoglobin concentration drops during
gestation [2], and for such reason the hemoglobin cutoﬀ
t od e ﬁ n ea n e m i aw a ss e ta t1 1 g / d Lo fH b[ 1]. Maternal
Hb levels are higher at high altitudes in all trimesters of
pregnancy than at sea level [3]. However, the reduction of
hemoglobin levels during pregnancy occurs in populations
at low and at high altitudes [3].
This is due to plasma volume expansion as a mechanism
to improve arterial uterine ﬂow to the placentae [4].
High arterial uterine blood ﬂow is associated with better
birthweight [5].
Several studies have shown that prevalence of anemia
increases from ﬁrst to third trimester [6]. Thus, a normal
Hb value at ﬁrst booking in the ﬁrst trimester does not
preclude the presence of anemia in a second measurement of
hemoglobin as pregnancy advances. A recent study showed
a higher risk for anemia in pregnant women with low body
mass index (BMI) [7]. Underweight is a common condition
in developing countries [8]. Since, anemia, particularly
moderate and severe anemia is associated with high risk2 ISRN Obstetrics and Gynecology
for low birthweight [3, 9, 10], it is important to monitor
hemoglobin values during pregnancy.
The present study has been designed to determine
changes in hemoglobin concentration at second mea-
surements after a normal hemoglobin concentration was
detected at ﬁrst booking during pregnancy at low and at
high altitudes. We will determine rates of anemia, normal
hemoglobin values and erythrocytosis (Hb >14.5g/dL). In
addition, risk factors for moderate/severe anemia will be
assessed in a multivariable analysis.
2. Methods
Thisisasecondaryanalysisofalargedatabaseobtainedfrom
the Perinatal Information System in Peru which includes
379,816 pregnant women and their babies obtained from
43 Maternity units in Peru. Data were obtained at the three
geographical regions in Peru: coast, highlands, and Amazon.
The study was authorized by the Institutional Review Board
at the Universidad Peruana Cayetano Heredia. As the study
used secondary analysis of data, the study was exempt from
formal review.
From the total sample size, a selection was made of all
women diagnosed as nonanemic and without erythrocytosis
at ﬁrst booking (Hb ranging from 11 to 14.5g/dL) and
having a second measurement of hemoglobin during the
same pregnancy. This subsample includes 89,294 pregnant
women. From these, 57,231 pregnant women were living at
low altitude (<2000m), 11,349 women at moderate altitude
(2000–3000m), and 20,714 women were living at high
altitudes (>3000m).
Data corresponds to pregnancies that occurred between
2000 and 2010. Data on gestational age at ﬁrst and second
hemoglobin measurement were recorded. With a second
hemoglobin value, rates of pregnant women with anemia
(Hb < 11 g/dL), normal hemoglobin values (11–14.5g/dL),
and erythrocytosis (Hb>14.5g/dL) were determined.
As demonstrated previously, no correction of hemo-
globin cutoﬀ to deﬁne anemia at high altitude is needed
[3]; hence, the present study used the deﬁnition of anemia
as suggested WHO for populations at sea level [1, 11]. The
degrees of anemia were classiﬁed as mild (Hb 9.0–10.9g/dL),
moderate (Hb 7.0–< 9g/dL), and severe (Hb < 7g/dL).
Body mass index was calculated from prepregnancy body
weight and height. Data were self-reported. Low BMI was
deﬁned as <19.9Kg/m2 and high BMI as >25Kg/m2.
Altitude was deﬁned as low (0–1999m), moderate
(2000–2999m), and high (≥ 3000m) [10].
The following perinatal outcomes were assessed: still-
births, preterm deliveries and small for gestational age.
Stillbirths were diagnosed when fetal deaths occurred after
20 weeks of gestation or with a weight higher than 500g.
Preterm births were deﬁned as deliveries before 37 weeks
of gestational age. Small for gestational age was deﬁned if
birthweight was below the 10th percentile of the Williams
reference chart [12].
The adverse maternal outcomes assessed were pree-
clampsia, premature rupture of membranes (PROM), and
postpartum hemorrhage (PPH). Preeclampsia was deﬁned
as the presence of pregnancy-induced hypertension (sys-
tolic pressure of ≥140mmHg and/or diastolic pressure
of ≥90mmHg) and proteinuria (≥300mg/24h) after 20
weeks of gestation. PROM was deﬁned as rupture of fetal
membranes previous to the onset of labor. PPH was deﬁned
as women after parturition with blood losses of 500mL or
more.
Data were assessed using the STATA program (Stata ver.
10) (Stata, College Station, TX). Data are assessed according
level of altitude (low, moderate, and high) and according to
degree of anemia (moderate/severe and mild), and erythro-
cytosis.Quantitativedatawereexpressedasmean ±standard
deviation (SD). Homogeneity of variance was performed
with the Breslow-Day test. If data were normally distributed,
then a one-way analysis of variance were used (ANOVA).
Diﬀerences between pair of means were assessed by the
Scheﬀe’s test. Data expressed in proportions were assessed
by the Chi-square test. The Conﬁdence interval (CI) was
deﬁned at 95% for each variable. The prevalences of women
with moderate/severe anemia (Hb <9g/dL), mild anemia
(Hb 9–10.9g/dL), normal hemoglobin (Hb 11–14.5g/dL),
and erythrocytosis (Hb >14.5g/dL) were calculated for the
total sample, as well as for groups at diﬀerent altitudes (low,
moderate,andhighaltitude).Adverseperinatalandmaternal
outcomes were assessed according level of hemoglobin at
second measurement. Estimates of crudes and adjusted odds
ratio (OR) with 95% CI were computed as measures of
associationbetweenthevariables.AdjustedORswerederived
through logistic regression models. A logistic regression
analysis to determine the risk for moderate/severe anemia
at second hemoglobin measured was assessed. The estimates
were adjusted for gestational age at second hemoglobin,
hemoglobin value at ﬁrst measurement, altitude, maternal
age, body mass index, maternal education, marital status,
prenatal care visits, parity, the presence of preeclampsia,
cardiopathy, and diabetes. Signiﬁcance was deﬁned at a value
of P<0.05 for all statistical analysis.
3. Results
Concentration of hemoglobin at ﬁrst booking in nonanemic
women increased as altitude increased (P<0.05), whereas
birthweight decreased as altitude increased. No diﬀerences
were observed in gestational age at birth at the three
altitude groups studied. Concentration of hemoglobin at
second measurement also was increased as altitude increases,
but values were lower than those at ﬁrst measurement,
particularly at low altitude, in which values were reduced
to 94%, whereas at moderate altitude. They were reduced to
98.4% and at high altitude to 99.2%. Gestational age at ﬁrst
and second hemoglobin was higher as altitude of residence
increased (Table 1).
Most of the studied sample remained with normal
hemoglobin values at second hemoglobin measurement
(75.1). However, 21.4% of women became anemic at the
second Hb measurement. In all, 2.8% resulted with moder-
ate/severe anemia and 3.5% with erythrocytosis (Figure 1).ISRN Obstetrics and Gynecology 3
Table 1: Concentration of maternal hemoglobin (Hb) at ﬁrst and second booking, gestational age (GA) at ﬁrst and second hemoglobin
measurement, gestational age at delivery and birthweight in populations at low, and moderate and high altitude in Peru.
Altitude
1st Hb (g/dL) 2nd Hb (g/dL) GA 1st Hb (weeks) GA 2nd Hb (weeks) Gestational age (weeks) Birthweight (g)
X ± SD X ± SD X ± SD X ± SD X ± SD X ± SD
Low 12.1 0.80 11.4 1.34 17.2 8.2 36 11.6 38.9 1.76 3262 512
Moderate 12.7 0.90 12.5 1.43 19.4 8.36 36.7 4.6 38.8 2.07 3123 529
High 13.0 0.88 12.9 1.40 20.6 8.3 37.3 3.9 38.8 1.89 3095 489
P <0.05 <0.05 <0.05 <0.05 <0.05
Total 12.4 0.91 11.9 1.52 18.3 8.4 36 4.5 38.9 1.83 3206 515
g/dL = grams per deciliter; P = Probability. One-way ANOVA. P<0.05 for each column except gestational age (P>0.05).
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Figure 1: Rates of moderate/severe anemia, mild anemia, normal hemoglobin values (Hb: 11–14.5 g/dL), and erythrocytosis (Hb>14.5
g/dL) in the second hemoglobin measurements in pregnant women diagnosed as nonanemic at ﬁrst booking in Peru.
Women with anemia in the second Hb measurement
showed lower Hb measurements in the ﬁrst Hb. Conversely,
women with erythrocytosis at the second Hb measurement
showed higher Hb levels in the ﬁrst measurement (Table 2).
In all cases Hb was higher as altitude increased.
The rate of stillbirths was higher with moderate/severe
anemia and with erythrocytosis (P<0.05), which remained
higher after controlling for confounders (Table 3).
The rate of preterm births was increased in women
with severe anemia (9.01%; OR = 1.81). After adjusting
for confounders, moderate/severe anemia (OR = 1.73) and
mild anemia (OR = 1.28) were risks for preterm deliveries
(Table 4).
The rate of SGA was signiﬁcantly higher in mothers with
erythrocytosis, almost twice, than in women with normal
hemoglobin. Lowest rate of SGA was observed with a mater-
nal Hb level of 9–10.9g/dL (mild anemia) (Table 5).
Therateofpreeclampsiawassigniﬁcantlyhigherinmod-
erate/severe and mild anemia and in mothers with erythro-
cytosis, which remained after controlling for confounders
(Table 6). Erythrocytosis reduced risk for PROM (Table 7).
PPH increased signiﬁcantly with mild and moder-
ate/severe anemia. The highest risk for PPH was observed
with moderate/severe anemia (twenty times higher than in
woman with normal Hb levels) (Table 8).
An increased risk for moderate/severe anemia was asso-
ciated with higher gestational age at second measurement
of hemoglobin, BMI < 19.9kg/m2, living without part-
ner, prenatal visits care <5, ﬁrst parity, multiparity, and
preeclampsia.
Lower risk for moderate/severe anemia were observed
withnormalhighHblevelatﬁrstbooking,livingatmoderate
and high altitude, and with high BMI (Table 9).
4. Discussion
The present study has been designed to determine changes
in Hb levels after a ﬁrst Hb measurement in 89,294 pregnant
women detected normality (Hb 11–14.5g/dL). According to
the study results 21.4% of these women become anemic.
An increase in the rate of anemia according to pregnancy
progress has been previously published in other settlings [6].
Moderate/severe anemia has been characterized as the con-
ditions more associated with maternal and perinatal adverse
outcomes. Our results demonstrated that 2.8% of women
classiﬁed as nonanemic in the ﬁrst Hb measurement showed4 ISRN Obstetrics and Gynecology
Table 2: Maternal hemoglobin values at ﬁrst booking in women diagnosed as anemic (moderate/severe and mild), normal or erythrocytic
at second hemoglobin measurement∗.
Altitude (sample)
Maternal hemoglobin (g/dL) at ﬁrst booking
Moderate/severe∗ Mild∗ Normal (Hb: 11–14.5g/dL)∗ Hb > 14.5g/dL ∗
X ± SD X ± SD X ± SD X ± SD
Total (89,294) 12.10 0.84 12.10 0.82 12.50 0.91 13.19 0.86
Low (57,231) 11.99 0.77 12.02 0.77 12.22 0.81 12.51 0.87
Moderate (11,349) 12.55 0.87 12.47 0.93 12.74 0.89 13.06 0.86
High (20,714) 12.66 0.94 12.70 0.94 13.03 0.87 13.33 0.81
ANOVA one way. P<0.05 except moderate/severe anaemia: moderate altitude versus high altitude P = 0.293.
Table 3: Crude and adjusted models to evaluate the association between the value of the second measurement of maternal hemoglobin (Hb)
and stillbirths in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
Stillbirths (n = 846)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 68 2.64 3.06∗ 2.76∗ 2.11 3.62
9–10.9 16,576 140 0.84 0.96 1.02 0.84 1.25
11–14.5 67,022 587 0.88 1.0 1.0
>14.5 3,121 51 1.63 1.88∗ 1.48∗ 1.09 2.04
∗Crude OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal
care, parity, gestational diabetes, and cardiopathy (current pregnancy).
Table 4: Crude and adjusted models to evaluate the association between the value of the second measurement of maternal hemoglobin (Hb)
and preterm births in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
Preterm Births (n = 4,932)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 232 9.01 1.81∗ 1.73∗ 1.49 2.00
9–10.9 16,576 1,043 6.29 1.23∗ 1.28∗ 1.19 1.38
11–14.5 67,022 3,468 5.17 1.0 1.0
>14.5 3,121 189 6.06 1.18∗ 1.02 0.87 1.20
∗OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal care,
parity, preeclampsia, gestational diabetes and cardiopathy, and infection of urinary tract (current pregnancy).
Table 5: Crude and adjusted models to evaluate the association between the value of the second measurement of maternal hemoglobin (Hb)
and small for gestational age in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
SGA (n = 9,239)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 243 9.44 0.88 0.87∗ 0.76 1.00
9–10.9 16,576 1,333 8.04 0.74∗ 0.82∗ 0.77 0.88
11–14.5 67,022 7,040 10.5 1.0 1.0
>14.5 3,121 623 19.9 2.12∗ 1.66∗ 1.51 1.83
∗OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal care,
parity, preeclampsia, gestational diabetes and cardiopathy, (current pregnancy), and history of low birthweight.
moderate/severeanemiainthesecondmeasurement.Thus,it
is important to monitor Hb levels at least twice during preg-
nancy. Our data showed that moderate/severe anemia were
associated with stillbirths, preterm births, preeclampsia, and
PPH.
The strength of this study is that it was done thanks
to a large sample of women recorded through a Perinatal
Information System that included 379,816 pregnant women
and their newborn babies from diﬀerent maternity units
throughout Peru. This database is an important tool forISRN Obstetrics and Gynecology 5
Table 6: Crude and adjusted models to evaluate the association between the value of second measurement of maternal hemoglobin (Hb)
and preeclampsia in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
Preeclampsia (n = 5,385)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 283 10.9 2.02∗ 1.92∗ 1.69 2.19
9–10.9 16,576 1,041 6.28 1.09∗ 1.06 0.99 1.14
11–14.5 67,022 3,851 5.75 1.0 1.0
>14.5 3,121 210 6.73 1.18∗ 1.32∗ 1.14 1.53
∗OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal care,
parity, gestational diabetes and cardiopathy, infection of urinary tract (current pregnancy), and history of preeclampsia.
Table 7: Crude and adjusted models to evaluate the association between the value of the second measurement of maternal hemoglobin (Hb)
and premature rupture of membranes (PROM) in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
PROM (n = 5,821)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 158 6.14 0.90 0.92 0.78 1.09
9–10.9 16,576 999 6.03 0.89∗ 0.93 0.86 1.00
11–14.5 67,022 4,498 6.71 1.0 1.0
>14.5 3,121 166 5.32 0.78∗ 0.71∗ 0.60 0.84
∗OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal care,
parity, preeclampsia, gestational diabetes, cardiopathy, and infection of urinary tract (current pregnancy).
Table 8: Crude and adjusted models to evaluate the association between the value of the second measurement of maternal hemoglobin (Hb)
and postpartum hemorrhage (PPH) in women with normal hemoglobin levels (11–14.5g/dL) at ﬁrst booking in Peru.
Maternal Hb
(g/dL)
Sample
N
PPH (n = 728)
n % Crude OR Adjusted OR CI at 95%
<9 2,575 219 8.50 19.3∗ 20.4∗ 16.9 24.5
9–10.9 16,576 175 1.06 2.21∗ 2.59∗ 2.14 3.14
11–14.5 67,022 321 0.48 1.0 1.0
>14.5 3,121 13 0.42 0.86 0.73 0.41 1.27
∗OR P<0.05. Model adjusted for gestational age at ﬁrst Hb, maternal age, altitude, maternal education, marital status, body mass index, antenatal care,
parity, preeclampsia, gestational diabetes and cardiopathy (current pregnancy).
Table 9: Risk for moderate/severe anemia at second measurement in women with normal hemoglobin (Hb) levels (11–14.5g/dL) at ﬁrst
booking in Peru.
Risk for moderate/severe anemia Odds ratio S.E ZP > Z95% CI
Gestational age at 2nd Hb
Hb at ﬁrst booking
Moderate altitude
High altitude
Age <20 years
Age >34 years
BMI <19.9kg/m2
BMI >25.0Kg/m2
Low education level
Without partner
Prenatal care <5
First parity
Parity ≥3
Preeclampsia
Cardiopathy
Gestational diabetes
1.05∗
0.74
0.57
0.40
1.07
0.97
1.19∗
0.84
1.01
1.16∗
1.13∗
1.14∗
1.25∗
1.96∗
2.09
1.80
0.006
0.019
0.041
0.028
0.056
0.074
0.071
0.041
0.054
0.067
0.047
0.056
0.117
0.128
0.891
0.832
9.21
−11.60
−7.62
−12.92
1.24
−0.43
2.87
−3.52
0.13
2.64
2.98
2.60
2.38
10.28
1.74
1.26
0.000
0.000
0.000
0.000
0.216
0.668
0.004
0.000
0.900
0.008
0.003
0.009
0.017
0.000
0.083
0.207
1.04–1.07
0.70–0.78
0.49–0.66
0.35–0.46
0.96–1.18
0.83–1.12
1.06–1.33
0.76–0.93
0.91–1.12
1.04–1.30
1.04–1.23
1.03–1.25
1.04–1.50
1.72–2.23
0.91–4.82
0.72–4.45
Number of observations: 89,294 mothers. ∗Signiﬁcant at 5% level.6 ISRN Obstetrics and Gynecology
monitoring conditions and trends related to pregnancies and
newborns, including service characteristics and women’s risk
factors.
Data revealed that a percentage of women became
anemic during the progression of pregnancy despite having a
ﬁrst normal Hb measurement. This is an important ﬁnding
since moderate and severe anemia are harmful for mothers
and neonates [13]. Risks for moderate/severe anemia are
preventable, or can be managed through appropriate man-
agement, such as with prenatal care, parity, preeclampsia,
and low BMI. Increasing the number of prenatal visits will
result in better monitoring of hemoglobin values, and can
control or reduce the eﬀect of preeclampsia. Low BMI is
a characteristic of low-income countries and is associated
with increased risk of maternal anemia, low birthweight, and
pretermbirths[7].Thepresentresultsareinaccordancewith
other studies where low prevalence of anemia was observed
in women with highest BMI, and high prevalence of moder-
ate/severeanemiawereassociatedwithmalnutrition[14,15].
Our data suggest that in situation in which a normal
hemoglobin value was ﬁrst observed in a woman with low
body mass index, supplementation with iron should be
recommended.
It is interesting to note that populations living at mod-
erate and high altitudes had lower risk for moderate/severe
anemia in a second measurement of hemoglobin during
pregnancy. This suggests that women living in these altitudes
bearing normal hemoglobin values at ﬁrst booking should
not be treated with iron supplementation. In recent years,
it has been demonstrated that anemia deﬁned as less than
11g/dLofHbisloweratmoderateandathighaltitudes,since
populations at these altitudes are characterized by increased
hemoglobin values to compensate for the eﬀect of altitudinal
hypoxia [3, 10].
4.1. Limitations. The database does not provide information
about the etiology of anemia. However, we assumed that
most cases of anemia were related to iron deﬁciency, which
was supported by the ﬁnding that low BMI was associated
with moderate/severe anemia. Prepregnancy weight was
measured by self-reported interviews. This may be aﬀected
by recall bias. However, results of our analysis were similar
to those obtained in a study in which BMI was obtained
at ﬁrst prenatal care [7]. The absence of daily food intake
information was another limitation of the study. In addition,
data on iron supplementation was not recorded in the
SIP. It is possible that erythrocytosis found in the second
measurement of Hb after a normal value of Hb at ﬁrst
booking could be due to the eﬀect of iron supplementation,
since in Peru a Ministry of Healthregulation orders pregnant
women be supplemented with iron. However, low adherence
may explain the low prevalence of erythrocytosis in a second
Hb measurement during pregnancy [16].
5. Conclusions
The results of this study conﬁrm that prevalence of anemia
increases as pregnancy progresses and that a normal value at
ﬁrst booking should not be considered suﬃcient, as further
hb values should be indicated and observed during the
course of pregnancy. low BMI was an important risk for
anemia in a second measurement.
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